Cartilage Repair Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: August 08, 2023 Report Code: GDME1598EPD-ST

Select Item

Cartilage Repair Pipeline Market Report Overview

Cartilage repair procedures aim to regenerate, restore or replace articular cartilage to reduce joint pain and to prevent the development of arthritis. Cartilage repair interventions can occur early in the spectrum of joint damage and offer an opportunity for patients to delay or altogether avoid needing total joint replacement surgery.

The cartilage repair pipeline market research report provides comprehensive information about the cartilage repair pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Extracellular Matrix Implants

·       Intact Tissue Implants

·       Osteochondral Allograft
Key Territories ·       United States

·       Europe

·       China

·       Australia

·       Canada

·       Singapore

·       South Korea

·       Taiwan

·       Others
Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       NMPA

·       Ninsho

·       TGA

·       UKCA
Leading Companies ·       3D Bio Corp

·       Acro Biomedical Co Ltd

·       Aesculap Biologics LLC

·       Anika Therapeutics Inc

·       Biomimedica, Inc.

·       Cartilage Inc

·       Gunze Ltd

·       Histogen Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cartilage Repair Pipeline Market by Segments

The key segments in the cartilage repair pipeline market are extracellular matrix implants, intact tissue implants, osteochondral allograft. As of August 2023, extracellular matrix implants have the highest number of pipeline products. These implants are decellularized implants that match or mimic the 3D structure of cartilage. They provide endogenous stem cells (chondrocytes) both a scaffold on which to grow, and a full complement of extracellular growth signals. This method of cartilage repair relies upon the stimulation of endogenous stem cells to restore damaged or lost cartilage.

Cartilage Repair Pipeline Market Analysis by Segments, 2023 (%)

Cartilage Repair Pipeline Market Analysis by Segments, 2023 (%)

Buy full report for insights on cartilage repair pipeline market segments

Download a free report sample

Cartilage Repair Pipeline Market Segmentation by Territories

Some of the key territories in the cartilage repair market are the United States (US), Europe, China, Australia, Canada, Singapore, and Taiwan among others. As of August 2023, the US has the highest number of pipeline products.

Cartilage Repair Pipeline Market Analysis by Territories, 2023 (%)

Cartilage Repair Pipeline Market Analysis by Territories, 2023 (%)

Buy full report with detailed territory insights of the cartilage repair pipeline market

Download a free report sample

Cartilage Repair Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the cartilage repair pipeline market are 510(k), CE, PMA, NMPA, Ninsho, TGA, and UKCA among others. As of August 2023, 510(k) is the most followed pathway for pipeline products in the market.

Cartilage Repair Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Cartilage Repair Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy full report for more regulatory path insights into the cartilage repair pipeline market

Download a free report sample

Cartilage Repair Pipeline Market – Competitive Landscape

Some of the key companies in the cartilage repair pipeline market are 3D Bio Corp, Biomimedica, Inc., Forsagen LLC, Gunze Ltd, Histogen Inc, Lamina Therapeutics, Meidrix GmbH, and Nanochon LLC among others.

3D Bio Corp: The company is a biologics and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company’s pipeline products include AuriNovo, AnnuNovo, DiscNovo and NasaNovo. The company provides bio printing platform which focuses on whole tissue living implants for near term indications.

Gunze Ltd: The company manufactures and supplies plastic films, engineering plastics, electronic components, innerwear, leg wear, house casual wear and other products. The company also offers various services such as insurance agency business services, engineering business services, landscaping and greening business services, and sports club operational services.

Cartilage Repair Pipeline Market Analysis by Companies, 2023

Cartilage Repair Pipeline Market Analysis by Companies, 2023

Download a free report sample and buy a full report for more company insights into the cartilage repair pipeline market

Segments Covered in the Report

Cartilage Repair Pipeline Market Segments Outlook

  • Extracellular Matrix Implants
  • Intact Tissue Implants
  • Osteochondral Allograft

Cartilage Repair Pipeline Market Territories Outlook

  • The US
  • Europe
  • Australia
  • China
  • South Africa
  • South Korea

Cartilage Repair Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • TGA
  • NIFDS
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the cartilage repair under development.

  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of cartilage repair and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of cartilage repair under development

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3D Bio Corp
Acro Biomedical Co Ltd
Aesculap Biologics LLC
Anika Therapeutics Inc
Askel Healthcare Ltd
Biomimedica, Inc.
Cartilage Inc
CoreSpine Technologies LLC
Department of Biomedical Engineering Columbia University
Forsagen LLC
Gunze Ltd
Hainan Susheng Biological Technology Co Ltd
Histogen Inc
Hy2Care BV
Hyalex Orthopaedics Inc
Isto Biologics
Kytogenics Pharmaceuticals Inc
L&C Bio
Lamina Therapeutics
Meidrix GmbH
Nanochon LLC
Novatex Bioengineering SA
Ocugen Inc
Olympus RMS Co Ltd
Regentis Biomaterials Ltd
Rosivo Inc
Royal College of Surgeons Ireland
Ruilin Biomedical Nanjing Co Ltd
Sparta Biomedical Inc
Stemmatters Biotecnologia e Medicina Regenerativa SA
Tetratherix Pty Ltd
University of Alberta
University of Oulu
University of Pennsylvania
Vericel Corp
Zimmer Biomet Holdings Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 9

2 Introduction 10

2.1 Cartilage Repair Overview 10

3 Products under Development 11

3.1 Cartilage Repair – Pipeline Products by Stage of Development 11

3.2 Cartilage Repair – Pipeline Products by Segment 12

3.3 Cartilage Repair – Pipeline Products by Territory 13

3.4 Cartilage Repair – Pipeline Products by Regulatory Path 14

3.5 Cartilage Repair – Pipeline Products by Estimated Approval Date 15

3.6 Cartilage Repair – Ongoing Clinical Trials 16

4 Cartilage Repair – Pipeline Products under Development by Companies 17

4.1 Cartilage Repair Companies – Pipeline Products by Stage of Development 17

4.2 Cartilage Repair – Pipeline Products by Stage of Development 19

5 Cartilage Repair Companies and Product Overview 21

5.1 3D Bio Corp Company Overview 21

5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Acro Biomedical Co Ltd Company Overview 22

5.2.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Aesculap Biologics LLC Company Overview 23

5.3.1 Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Anika Therapeutics Inc Company Overview 28

5.4.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Askel Healthcare Ltd Company Overview 32

5.5.1 Askel Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.6 Biomimedica, Inc. Company Overview 35

5.6.1 Biomimedica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

5.7 Cartilage Inc Company Overview 36

5.7.1 Cartilage Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 CoreSpine Technologies LLC Company Overview 37

5.8.1 CoreSpine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.9 Department of Biomedical Engineering Columbia University Company Overview 38

5.9.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 Forsagen LLC Company Overview 39

5.10.1 Forsagen LLC Pipeline Products & Ongoing Clinical Trials Overview 39

5.11 Gunze Ltd Company Overview 40

5.11.1 Gunze Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.12 Hainan Susheng Biological Technology Co Ltd Company Overview 43

5.12.1 Hainan Susheng Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.13 Histogen Inc Company Overview 44

5.13.1 Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.14 Hy2Care BV Company Overview 45

5.14.1 Hy2Care BV Pipeline Products & Ongoing Clinical Trials Overview 45

5.15 Hyalex Orthopaedics Inc Company Overview 48

5.15.1 Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Isto Biologics Company Overview 53

5.16.1 Isto Biologics Pipeline Products & Ongoing Clinical Trials Overview 53

5.17 Kytogenics Pharmaceuticals Inc Company Overview 54

5.17.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.18 L&C Bio Company Overview 55

5.18.1 L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 55

5.19 Lamina Therapeutics Company Overview 58

5.19.1 Lamina Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 58

5.20 Meidrix GmbH Company Overview 59

5.20.1 Meidrix GmbH Pipeline Products & Ongoing Clinical Trials Overview 59

5.21 Nanochon LLC Company Overview 60

5.21.1 Nanochon LLC Pipeline Products & Ongoing Clinical Trials Overview 60

5.22 Novatex Bioengineering SA Company Overview 61

5.22.1 Novatex Bioengineering SA Pipeline Products & Ongoing Clinical Trials Overview 61

5.23 Ocugen Inc Company Overview 62

5.23.1 Ocugen Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.24 Olympus RMS Co Ltd Company Overview 63

5.24.1 Olympus RMS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.25 Regentis Biomaterials Ltd Company Overview 64

5.25.1 Regentis Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.26 Rosivo Inc Company Overview 68

5.26.1 Rosivo Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.27 Royal College of Surgeons Ireland Company Overview 70

5.27.1 Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview 70

5.28 Ruilin Biomedical Nanjing Co Ltd Company Overview 71

5.28.1 Ruilin Biomedical Nanjing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

5.29 Sparta Biomedical Inc Company Overview 74

5.29.1 Sparta Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.30 Stemmatters Biotecnologia e Medicina Regenerativa SA Company Overview 75

5.30.1 Stemmatters Biotecnologia e Medicina Regenerativa SA Pipeline Products & Ongoing Clinical Trials Overview 75

5.31 Tetratherix Pty Ltd Company Overview 76

5.31.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 76

5.32 University of Alberta Company Overview 77

5.32.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 77

5.33 University of Oulu Company Overview 78

5.33.1 University of Oulu Pipeline Products & Ongoing Clinical Trials Overview 78

5.34 University of Pennsylvania Company Overview 79

5.34.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 79

5.35 Vericel Corp Company Overview 80

5.35.1 Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview 80

5.36 Zimmer Biomet Holdings Inc Company Overview 85

5.36.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 85

6 Appendix 86

6.1 Methodology 86

6.2 About GlobalData 89

6.3 Contact Us 89

6.4 Disclaimer 89

Table

Cartilage Repair – Pipeline Products by Stage of Development 11

Cartilage Repair – Pipeline Products by Segment 12

Cartilage Repair – Pipeline Products by Territory 13

Cartilage Repair – Pipeline Products by Regulatory Path 14

Cartilage Repair – Pipeline Products by Estimated Approval Date 15

Cartilage Repair – Ongoing Clinical Trials 16

Cartilage Repair Companies – Pipeline Products by Stage of Development 17

Cartilage Repair – Pipeline Products by Stage of Development 19

3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 21

3D Printed Implant – Damaged Meniscus – Product Status 21

3D Printed Implant – Damaged Meniscus – Product Description 21

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

ACROCHONDRO – Product Status 22

ACROCHONDRO – Product Description 22

Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Novocart – Ankle – Product Status 23

Novocart – Ankle – Product Description 23

Novocart – Hip – Product Status 24

Novocart – Hip – Product Description 24

Novocart 3D – Product Status 24

Novocart 3D – Product Description 25

Novocart 3D Plus – Product Status 25

Novocart 3D Plus – Product Description 25

Aesculap Biologics LLC – Ongoing Clinical Trials Overview 26

Novocart 3D – Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture 27

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Hyalofast – Product Status 28

Hyalofast – Product Description 29

Anika Therapeutics Inc – Ongoing Clinical Trials Overview 30

Hyalofast – A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 31

Hyalofast – A Study on the Safety and Effectiveness of Improved Microfracture Techniques Using Temperature Sensitive Polymer Hydrogel for Femoral and Cartilage Defects- Prospective, Randomize, Single-center 31

Askel Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

COPLA Cartilage Implant – Product Status 32

COPLA Cartilage Implant – Product Description 32

Askel Healthcare Ltd – Ongoing Clinical Trials Overview 33

COPLA Cartilage Implant – Pilot Clinical Trial to Evaluate the Preliminary Safety and Performance of COPLA for Treatment of Cartilage Defects 34

Biomimedica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

GRADION Hip Total Cartilage Replacement (TCR) Device – Product Status 35

GRADION Hip Total Cartilage Replacement (TCR) Device – Product Description 35

Cartilage Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Hyaleon – Product Status 36

Hyaleon – Product Description 36

CoreSpine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Cartilage Removal System – Product Status 37

Cartilage Removal System – Product Description 37

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 38

Echon – Product Status 38

Echon – Product Description 38

Forsagen LLC Pipeline Products & Ongoing Clinical Trials Overview 39

BioAdhesive – Product Status 39

BioAdhesive – Product Description 39

Gunze Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Meniscal Scaffold – Product Status 40

Meniscal Scaffold – Product Description 40

Gunze Ltd – Ongoing Clinical Trials Overview 41

Meniscal Scaffold – An Exploratory Clinical Study of Gunze’s Biodegradable Scaffold for Meniscal Repair in Patients with Knee Pain 42

Hainan Susheng Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

Acellular Cartilage Repair Device – Product Status 43

Acellular Cartilage Repair Device – Product Description 43

Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 44

HST003 – Product Status 44

HST003 – Product Description 44

Hy2Care BV Pipeline Products & Ongoing Clinical Trials Overview 45

Injectable Plaster – Product Status 45

Injectable Plaster – Product Description 45

Hy2Care BV – Ongoing Clinical Trials Overview 46

Injectable Plaster – A Multi-center, Pivotal, Non-randomized, Prospective, Open-label Study to Evaluate the Safety and Performance of the Hy2Care Injectable Hydrogel for the Repair of Cartilage Defects in the Knee 47

Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Hyalex Cartilage Replacement Implant – Ankle – Product Status 48

Hyalex Cartilage Replacement Implant – Ankle – Product Description 48

Hyalex Cartilage Replacement Implant – Foot – Product Status 49

Hyalex Cartilage Replacement Implant – Foot – Product Description 49

Hyalex Cartilage Replacement Implant – Hand – Product Status 49

Hyalex Cartilage Replacement Implant – Hand – Product Description 50

Hyalex Cartilage Replacement Implant – Hip – Product Status 50

Hyalex Cartilage Replacement Implant – Hip – Product Description 50

Hyalex Cartilage Replacement Implant – Knee – Product Status 51

Hyalex Cartilage Replacement Implant – Knee – Product Description 51

Hyalex Cartilage Replacement Implant – Shoulder – Product Status 51

Hyalex Cartilage Replacement Implant – Shoulder – Product Description 52

Hyalex Cartilage Replacement Implant – Wrist – Product Status 52

Hyalex Cartilage Replacement Implant – Wrist – Product Description 52

Isto Biologics Pipeline Products & Ongoing Clinical Trials Overview 53

RevaFlex – Product Status 53

RevaFlex – Product Description 53

Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 54

MACC (Mucoadhesive Cell Control Technology)-Based Device – Cartilage Repair – Product Status 54

MACC (Mucoadhesive Cell Control Technology)-Based Device – Cartilage Repair – Product Description 54

L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 55

MegaCarti Decellularized Allogeneic Cartilage – Product Status 55

MegaCarti Decellularized Allogeneic Cartilage – Product Description 55

L&C Bio – Ongoing Clinical Trials Overview 56

MegaCarti Decellularized Allogeneic Cartilage – Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti; Cartilage Defect Treatment Assisting Cartilage Regeneration in Knee Cartilage Defects: Multicenter, Independent Evaluator and Subject Blinded, Microfracture Comparative, Superiority, Randomized, Confirmatory Clinical Study and 5 Years Follow up Study 57

Lamina Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 58

Lamina.One – Product Status 58

Lamina.One – Product Description 58

Meidrix GmbH Pipeline Products & Ongoing Clinical Trials Overview 59

Resorbable Cartilage Regeneration Implant – Product Status 59

Resorbable Cartilage Regeneration Implant – Product Description 59

Nanochon LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Orthopedic Implant – Cartilage Repair – Product Status 60

Orthopedic Implant – Cartilage Repair – Product Description 60

Novatex Bioengineering SA Pipeline Products & Ongoing Clinical Trials Overview 61

Chondrofill – Product Status 61

Chondrofill – Product Description 61

Ocugen Inc Pipeline Products & Ongoing Clinical Trials Overview 62

NeoCart – Product Status 62

NeoCart – Product Description 62

Olympus RMS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Cultured Chondrocyte Implantation Kit – Product Status 63

Cultured Chondrocyte Implantation Kit – Product Description 63

Regentis Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

GelrinC – Product Status 64

GelrinC – Product Description 64

GelrinC – Denatured Human Fibrinogen – Product Status 65

GelrinC – Denatured Human Fibrinogen – Product Description 65

Regentis Biomaterials Ltd – Ongoing Clinical Trials Overview 66

GelrinC – Denatured Human Fibrinogen – A Prospective, Open-label, Multicenter Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle: A Comparison to Historical Control Microfracture 67

Rosivo Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Cartesse – Cartilage Repair – Product Status 68

Cartesse – Cartilage Repair – Product Description 68

Cartesse AC – Articular Cartilage Repair – Product Status 69

Cartesse AC – Articular Cartilage Repair – Product Description 69

Cartesse IVD – Intervertebral Disc Repair – Product Status 69

Cartesse IVD – Intervertebral Disc Repair – Product Description 69

Royal College of Surgeons Ireland Pipeline Products & Ongoing Clinical Trials Overview 70

miRNA-Activated Scaffold – Product Status 70

miRNA-Activated Scaffold – Product Description 70

Ruilin Biomedical Nanjing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

Articular Hyaline Cartilage Repair Device – Product Status 71

Articular Hyaline Cartilage Repair Device – Product Description 71

Meniscus Repair Device – Product Status 72

Meniscus Repair Device – Product Description 72

Osteochondral Repair Device – Product Status 72

Osteochondral Repair Device – Product Description 73

Sparta Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 74

SBM-01 Biomimetic Implant – Product Status 74

SBM-01 Biomimetic Implant – Product Description 74

Stemmatters Biotecnologia e Medicina Regenerativa SA Pipeline Products & Ongoing Clinical Trials Overview 75

STM-148B – Product Status 75

STM-148B – Product Description 75

Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 76

Tetraflex – Product Status 76

Tetraflex – Product Description 76

University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 77

3-D Printed Cartilage – Nose – Product Status 77

3-D Printed Cartilage – Nose – Product Description 77

University of Oulu Pipeline Products & Ongoing Clinical Trials Overview 78

Smart 3D Matrices – Chondral Repair – Product Status 78

Smart 3D Matrices – Chondral Repair – Product Description 78

University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 79

Injectable Polymer – Cartilage Repair – Product Status 79

Injectable Polymer – Cartilage Repair – Product Description 79

Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview 80

MACI – Product Status 80

MACI – Product Description 81

MACI – Ankle – Product Status 81

MACI – Ankle – Product Description 81

MACI – Pediatric Knee – Product Status 82

MACI – Pediatric Knee – Product Description 82

Vericel Corp – Ongoing Clinical Trials Overview 83

MACI – A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee 84

Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 85

ChonDux – Product Status 85

ChonDux – Product Description 85

Glossary 88

Figures

Cartilage Repair – Pipeline Products by Stage of Development 11

Cartilage Repair – Pipeline Products by Segment 12

Cartilage Repair – Pipeline Products by Territory 13

Cartilage Repair – Pipeline Products by Regulatory Path 14

Cartilage Repair – Pipeline Products by Estimated Approval Date 15

Cartilage Repair – Ongoing Clinical Trials 16

Frequently asked questions

Cartilage Repair Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cartilage Repair Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cartilage Repair reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cartilage Repair Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cartilage Repair Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more